NeuroTech Harbor is proud to share that NTH Technical Director Nitish Thakor's work on an advanced prosthetic hand that 'knows' what it is holding and carefully conforms and adjusts its grasp to avoid damaging or mishandling the object was recently featured in an online publication by Johns Hopkins University! Read more about Dr. Thakor's work here: https://lnkd.in/e3eMtC7w
关于我们
NeuroTech Harbor (NTH), a partnership between Johns Hopkins University and Howard University, is the Nation's first ecosystem for neuromedical solutions. Neurological disorders (including Alzheimer’s, Parkinson’s and MS) impact 1 in every 3 people in the US. With the help of cutting-edge technological solutions, we can revolutionize the way we diagnose, monitor, and treat these conditions NTH is part of the Blueprint MedTech program, an initiative designed to accelerate the development and commercialization of innovative medical devices for diagnosing and treating nervous system disorders. The program aims to "de-risk" technologies to attract further investment by providing funding, mentoring, resources, and expert guidance.
- 网站
-
https://neurotechharbor.org/
NeuroTech Harbor (NTH)的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 非营利机构
- 创立
- 2022
NeuroTech Harbor (NTH)员工
-
Santosh Venkatesha
-
William Daunch
Chief Technology Officer @ Focal Medical, Inc. | Medical Technology | Drug Delivery | Oncology | Gene Therapy | Analytical Chemistry | Polymer…
-
Ishir Sharma
Biomedical Engineering at The Johns Hopkins University
-
Kebreten Manaye
Professor and Chair at Howard University
动态
-
The 2025 Maryland MedTech Summit is fast approaching! Hosted by the University of Maryland Robert E. Fischell Institute for Biomedical Devices and the Maryland Department of Commerce, 2025 Maryland MedTech Summit is the cornerstone of the inaugural Maryland MedTech Week, a series of events promoting the burgeoning MedTech community in the DMV. Join medical device innovators, investors, universities, and the rest of the capital health region, for a full-day event to celebrate and build our medtech industry. Come for panels, breakout sessions, networking and opportunities to present your business needs, as we explore the impact and future of medtech in the DMV region and beyond, opportunities to participate in federal and regional initiatives, device manufacturing, go-to-market strategies, and more. Date: Tuesday, April 8th, 2025 Time: 9am - 5pm Location: Stamp Student Union, Colony Ballroom, University of Maryland College Park Learn more about the Summit and register for this year's event here: https://lnkd.in/erzdNent
-
NeuroTech Harbor is proud to share that NTH Executive Director Sri Sarma's work on EpiScalp, a diagnostic tool that could cut epilepsy misdiagnoses by nearly 70%, was recently featured in an online publication by Johns Hopkins University! Read more about EpiScalp here: https://lnkd.in/emqcx7wJ
-
Ethics are a longstanding hallmark of medical care. However, the novelty of neurotechnology and neuromedical interventions - both invasive and non-invasive - require a new rulebook. UNESCO is leading the charge in the field of neuroethics, bringing together experts from around the globe to codify standards of ethical care when leveraging neuromedical solutions. Learn more about UNESCO's efforts in the field of neuroethics here: https://lnkd.in/efYS4p6N
-
NeuroTech Harbor is proud to announce the launch of the NIH Blueprint MedTech Pathways Pilot Program! The NIH Blueprint Medtech Pathways pilot program is an immersive 12-week traineeship intended to educate and cultivate aspiring/early-stage innovators from groups historically underrepresented in biotech who are interested in the commercialization of neurotechnologies. The program will provide a unique educational experience tailored to neurotechnology and leverage resources from the NIH Blueprint Medtech program to provide guided hands-on experience, on-call mentorship, and clinical and technical networks for solution validation. The Pathways pilot aims to promote inclusive innovation, reduce barriers to commercialization and provide a pipeline to the broader NIH Blueprint Medtech ecosystem. Graduate students, post-docs, medical fellows & residents, and young faculty from HBCUs and MSIs with an?early-stage neurotechnology device idea?for development who have inadequate resources or knowledge of translation are encouraged to apply! Learn more about and apply to the the NIH Blueprint MedTech Pathways Pilot Program here: https://lnkd.in/eycvfBHi
-
According to research by S&S Insider, the meuroscience market, valued at $30.2 billion in 2023, is projected to reach a $50.2 billion valuation by 2032 growing at a CAGR of 4%. This growth is being driven by both increased awareness of neurological disorders and the rapid acceleration of neuromedical interventions for these disorders and other neurotechnologies. Read more about S&S Insider's report here: https://lnkd.in/ecnsPAgx
-
Earlier this year, neurotech startup Synchron announced that their brain implant successfully enabled hands-free use of Apple Vision Pro by a patient with ALS. This marks a large step towards their goal of building a brain-computer interface (BCI) that enables individuals with paralysis to control their personal electronics with their minds. Read more about Synchron's Apple Vision Pro use case here: https://lnkd.in/ew4qM22j
-
Researchers at the German Primate Center (DPZ)'s Neurobiology Laboratory have uncovered a novel solution for improving the everyday practicality of hand neuroprostheses. By analyzing the neural signals behind hand postures, researchers were able to demonstrate improved hand control skills in virtual hands in rhesus monkeys. This finding has the potential to inform the development of advanced neuroprostheses to equip patients with paralysis or neurodegenerative diseases with the fine motor skills necessary to complete daily tasks with their prosthesis. Read more about the research here: https://lnkd.in/eUenwumS
-
One week left to apply for neuromedical device funding is open! NeuroTech Harbor (NTH) and the Center for Innovative NeuroTech Advancement (CINTA) are now accepting applications for the Cycle 5 Award Competition supported by the NIH Blueprint MedTech Program. This program is seeking collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system that are aligned with the mission and interests of the participating NIH institutes and centers with the goal of catalyzing the translation of novel technologies from early-stage development to a prototype ready for first-in-human testing and will provide: (a) non-dilutive funds to support medical device development activities, (b) ongoing, specialized support from experienced executive mentors and (c) additional resources and support services. Read more about Blueprint MedTech and apply to Cycle 5 here: https://lnkd.in/e8b8U8Ax
-
-
Check out this article from the National Institutes of Health (NIH) highlighting Blueprint MedTech (BPMT)'s incubator programs, featuring teams who are currently receiving their first year of funding through the program! https://lnkd.in/eDFUmVmr BPMT is currently running its fifth solicitation for pre-proposals for collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system with a deadline of October 4th. Read more about and apply to BPMT's Cycle 5 solicitation here: https://lnkd.in/e8b8U8Ax
-